Security key
55279B202
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)
CUSIP: 55279B202
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Stock, $0.00000002 par value
- Shares outstanding
- 29,545,622
- Total 13F shares
- 6,302,427
- Share change
- +358,743
- Total reported value
- $10,208,000
- Price per share
- $1.62
- Number of holders
- 42
- Value change
- +$579,181
- Number of buys
- 29
- Number of sells
- 5
Report period
Q1 2017
Institutions
42
Top holders
10
MEIP full security history
Newer quarter: Q2 2017
Previous quarter: Q4 2016
Lite Strategy, Inc. SEC filings
Lite Strategy, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 55279B202
Recent filing periods:
Top shareholders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Anson Funds Management LP |
13F
|
Company |
4.6%
|
1,366,859
|
$1,968,000 | — | 31 Dec 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.3%
|
986,419
|
$1,420,000 | — | 31 Dec 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
615,963
|
$887,000 | — | 31 Dec 2016 | |
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
2%
|
580,401
|
$836,000 | — | 31 Dec 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.5%
|
448,639
|
$646,000 | — | 31 Dec 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
427,500
|
$616,000 | — | 31 Dec 2016 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.4%
|
403,175
|
$581,000 | — | 31 Dec 2016 | |
| Ancora Advisors LLC |
13F
|
Company |
1.1%
|
325,000
|
$468,000 | — | 31 Dec 2016 | |
| FMR LLC |
13F
|
Company |
1.1%
|
315,524
|
$454,000 | — | 31 Dec 2016 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.86%
|
253,757
|
$365,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
128,215
|
$184,000 | — | 31 Dec 2016 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.36%
|
105,410
|
$152,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.25%
|
73,394
|
$106,000 | — | 31 Dec 2016 | |
| KEYBANK NATIONAL ASSOCIATION/OH |
13F
|
Company |
0.2%
|
57,642
|
$83,000 | — | 31 Dec 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
56,717
|
$82,000 | — | 31 Dec 2016 | |
| SHEPHERD KAPLAN KROCHUK, LLC |
13F
|
Company |
0.17%
|
50,000
|
$72,000 | — | 31 Dec 2016 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0.14%
|
41,251
|
$59,000 | — | 31 Dec 2016 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.13%
|
39,411
|
$57,000 | — | 31 Dec 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
34,777
|
$50,000 | — | 31 Dec 2016 | |
| Virtu KCG Holdings LLC |
13F
|
Company |
0.11%
|
33,403
|
$48,000 | — | 31 Dec 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
22,085
|
$32,000 | — | 31 Dec 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
21,778
|
$31,000 | — | 31 Dec 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
16,757
|
$24,000 | — | 31 Dec 2016 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.06%
|
16,621
|
$23,000 | — | 31 Dec 2016 | |
| Gilman Hill Asset Management, LLC |
13F
|
Company |
0.05%
|
13,316
|
$19,000 | — | 31 Dec 2016 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.04%
|
12,407
|
$18,000 | — | 31 Dec 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.03%
|
8,459
|
$12,000 | — | 31 Dec 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
8,200
|
$12,000 | — | 31 Dec 2016 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
5,822
|
$8,000 | — | 31 Dec 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.02%
|
5,118
|
$7,000 | — | 31 Dec 2016 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0.01%
|
1,500
|
$2,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,195
|
$2,000 | — | 31 Dec 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
1,142
|
$2,000 | — | 31 Dec 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,008
|
$1,000 | — | 31 Dec 2016 |
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q1 2017
As of 31 Mar 2017,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,302,427 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, INTERWEST VENTURE MANAGEMENT CO, BlackRock Inc., Connor, Clark & Lunn Investment Management Ltd., FMR LLC, Ancora Advisors, LLC, WASATCH ADVISORS INC, BRIDGEWAY CAPITAL MANAGEMENT INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
33
Q1 2017 holders
42
Holder diff
9
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.